National Toxicology Program nomenclature for hepatoproliferative lesions of rats.
about
Liver tumors in male rats following treatment with glucocorticosteroidsDose-response relationships in promotion of rat hepatocarcinogenesis by 17 alpha-ethinylestradiolDose response for TCDD promotion of hepatocarcinogenesis in rats initiated with DEN: histologic, biochemical, and cell proliferation endpointsProceedings of the 2009 National Toxicology Program Satellite Symposium.Neoplasms and related proliferative lesions in control Sprague-Dawley rats from carcinogenicity studies. Historical data and diagnostic considerations.Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animalsDevelopment of an animal model for radiofrequency ablation of primary, virally induced hepatocellular carcinoma in the woodchuckProgenitor-derived hepatocellular carcinoma model in the rat.Skin and liver diseases induced in flounder (Platichthys flesus) after long-term exposure to contaminated sediments in large-scale mesocosms.Relationships between toxicopathic hepatic lesions and exposure to chemical contaminants in English sole (Pleuronectes vetulus), starry flounder (Platichthys stellatus), and white croaker (Genyonemus lineatus) from selected marine sites on the PacifBiochemical markers associated with the stages of promotion and progression during hepatocarcinogenesis in the rat.Relevance of animal carcinogenesis findings to human cancer predictions and prevention.Transgenic hepatocarcinogenesis in the ratComparative histomorphological review of rat and human hepatocellular proliferative lesions.Recent developments on the hazards posed by 2,3,7,8-tetrachlorodibenzo-p-dioxin in soil: implications for setting risk-based cleanup levels at residential and industrial sites.Expression of an epidermal keratin protein in liver of transgenic mice causes structural and functional abnormalities.Metformin inhibits early stage diethylnitrosamine‑induced hepatocarcinogenesis in rats.Review of pathology data for regulatory purposes.Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3Identifying soil cleanup criteria for dioxins in urban residential soils: how have 20 years of research and risk assessment experience affected the analysis?Inhibition of the promotion of hepatocarcinogenesis by 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153) by the deletion of the p50 subunit of NF-kappa B in mice.Consumption of fish: benefits and perceived risk.A brief review of modern toxicologic pathology in regulatory and explanatory toxicity studies of chemicals.Toxicology and human health assessment of decabromodiphenyl ether.Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system.Carcinogenicity of polyhalogenated biphenyls: PCBs and PBBs.Reevaluation of a twenty-four-month chronic toxicity/carcinogenicity study of hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) in the B6C3F1 hybrid mouse.Experimental chemical carcinogenesis in fish.Rapid bioassay methods for carcinogens and modifiers of hepatocarcinogenesis.Proliferative hepatocellular lesions of the rat: review and future use in risk assessment.Polychlorinated biphenyls (PCBs) and human health: an update.Mutational analysis of three tumor suppressor genes in two models of rat hepatocarcinogenesis.Problems in consideration of rodent hepatocarcinogenesis for regulatory purposes.Diagnostic criteria for degenerative, inflammatory, proliferative nonneoplastic and neoplastic liver lesions in medaka (Oryzias latipes): consensus of a National Toxicology Program Pathology Working Group.Tumor-promoting effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and phenobarbital in initiated weanling Sprague-Dawley rats: a quantitative, phenotypic, and ras p21 protein study.Risk assessment of 2,3,7,8-TCDD using a biologically based cancer model: a reevaluation of the Kociba et al. bioassay using 1978 and 1990 histopathology criteria.Classification of proliferative hepatocellular lesions in harlan sprague-dawley rats chronically exposed to dioxin-like compounds.Inhibition of hepatocarcinogenesis by the deletion of the p50 subunit of NF-kappaB in mice administered the peroxisome proliferator Wy-14,643.Aflatoxin induced hepatocarcinogenesis in ducks.Genome-wide loss of heterozygosity analysis of chemically induced rat hepatocellular carcinomas reveals elevated frequency of allelic imbalances on chromosomes 1, 6, 8, 11, 15, 17, and 20.
P2860
Q28316860-3C1643E3-47A5-4855-98A4-F400A99F0D93Q28334140-CF988BD0-038D-42E0-9B7F-4EA1F4465E40Q28369622-7D759625-28F1-4FC1-86B8-144CFC526452Q30591616-1DDE3739-275F-4522-8DB8-E43474DFC3A8Q30891582-912F20AB-3A82-4817-9BB6-868947619805Q33985264-9A3A410C-9007-4A64-ABC7-EC69FBD96506Q34035311-C4A46634-3F0D-4B99-840A-8C1763DBD2C4Q34037698-9E502BF3-F3B3-4975-AFA2-FB6B14985B53Q34636339-4C1A0576-F124-44C1-BD6F-C12D0E2D9078Q35031872-D5862732-C3BB-4955-8DDC-EFF6C8C14A8FQ35034179-CB6191F1-3E38-4835-89D9-DFF9AD499507Q35812499-5AAC09AC-6F04-493E-9D3C-3F6BCF5FDCC7Q35833953-FB844A52-B264-42FA-8B8E-A40132B1A148Q36210352-4C0E1F60-A4A9-443F-AB04-034BCE390D52Q36218600-8CCCA00C-F4ED-4BFD-9267-61F83FE846CDQ36235160-9B2BEB44-ADDC-4E7A-9919-35F675BA68FBQ36390358-36D92E8C-BFB8-43E5-BD5F-42171829707FQ36429132-775BE5F5-910F-42C1-A2B9-280514ABE8EDQ36446884-A206973F-C5E2-4274-BDD8-A1649BE3533BQ36448889-EE562918-34CC-43AF-BB7B-AD14A3932B33Q36973163-E4DFCED3-18B8-4A2A-9325-C041B6172F14Q37335123-CEE19A72-7BFD-4BF2-AF2B-9E454C4B821EQ37418253-CF518503-8670-4F7B-9E21-F4764C14EDD8Q37623786-C03D62EB-81C6-4065-8127-1517E1943837Q37824547-AE1AF943-FE1C-4B82-BD6E-80F9399122F7Q37886498-DC64B6FC-BD5A-4928-A2C1-24BA7599EFE6Q38436277-1332DE25-7BEE-45ED-BBB0-67CFD1F72461Q38560622-A4FFB762-B201-4629-9E74-C51D0D533051Q38656792-525F8BF8-5454-4B2A-8A3E-49CC3549498EQ39773641-C2959FFA-012C-43F7-AF41-9267C298F133Q40444768-66F013DD-76F6-457C-BB98-6097BFC3C514Q40941257-DFA75050-62C0-45E8-B15E-5CA84FDE08F1Q41137559-5F2810D0-2A34-4FBF-97B5-EBBE68325738Q41450253-D4067104-F57C-4813-B603-975FAD8442F7Q42280253-1323B6CE-3B1A-4577-9A27-7ED9DB2305EEQ44033528-A7B10FA4-E132-4F4C-A87F-F434EB558DD8Q46417388-BFC32DA8-79F8-4572-95B7-B069EBAAADDEQ46910008-72A33339-8048-4B08-AF5B-D461755E33BFQ47736058-1B168B26-CF93-4BEA-B783-6EC12EFA6258Q53409570-A7FBC77E-FB07-4901-A1DC-1575B07F661F
P2860
National Toxicology Program nomenclature for hepatoproliferative lesions of rats.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
National Toxicology Program nomenclature for hepatoproliferative lesions of rats.
@en
National Toxicology Program nomenclature for hepatoproliferative lesions of rats.
@nl
type
label
National Toxicology Program nomenclature for hepatoproliferative lesions of rats.
@en
National Toxicology Program nomenclature for hepatoproliferative lesions of rats.
@nl
prefLabel
National Toxicology Program nomenclature for hepatoproliferative lesions of rats.
@en
National Toxicology Program nomenclature for hepatoproliferative lesions of rats.
@nl
P2093
P2860
P1476
National Toxicology Program nomenclature for hepatoproliferative lesions of rats.
@en
P2093
C A Montgomery
E E McConnell
G A Boorman
R R Maronpot
P2860
P304
P356
10.1177/019262338601400217
P407
P577
1986-01-01T00:00:00Z